Frequently Asked Questions
The market is segmented based on , By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Amphotericin B Market size was valued at USD 0.22 USD Billion in 2022.
The Global Amphotericin B Market is projected to grow at a CAGR of 4.6% during the forecast period of 2023 to 2030.
The major players operating in the market include Bristol Myers Squibb Company, Matinas Biopharma Holdings , NanoX Imaging LTD, Nanomerics, DNDi, Abzena Ltd, Bharat Serums and Vaccines Limited, Astellas Pharma , Leadiant Biosciences , Lilly, InterMune, Jina Pharmaceuticals, SteriMax, XGen Pharmaceuticals DJB .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
